Sarcoid-Like Granulomatous Disease: Pathologic Case Series in World Trade Center Dust Exposed Rescue and Recovery Workers.
Vasanthi R SunilJared RadbelSabiha HussainKinal N VayasJessica CervelliMalik DeenHoward KipenIris UdasinRobert LaumbachJag SunderramJeffrey D LaskinDebra L LaskinPublished in: International journal of environmental research and public health (2019)
Sarcoid-like granulomatous diseases (SGD) have been previously identified in cohorts of World Trade Center (WTC) dust-exposed individuals. In the present studies, we analyzed lung and/or lymph node biopsies from patients referred to our clinic with suspected WTC dust-induced lung disease to evaluate potential pathophysiologic mechanisms. Histologic sections of lung and/or lymph node samples were analyzed for markers of injury, oxidative stress, inflammation, fibrosis, and epigenetic modifications. Out of seven patients examined, we diagnosed four with SGD and two with pulmonary fibrosis; one was diagnosed later with SGD at another medical facility. Patients with SGD were predominantly white, obese men, who were less than 50 years old and never smoked. Cytochrome b5, cytokeratin 17, heme oxygenase-1, lipocalin-2, inducible nitric oxide synthase, cyclooxygenase 2, tumor necrosis factor α, ADP-ribosylation factor-like GTPase 11, mannose receptor-1, galectin-3, transforming growth factor β, histone-3 and methylated histone-3 were identified in lung and lymph nodes at varying levels in all samples examined. Three of the biopsy samples with granulomas displayed peri-granulomatous fibrosis. These findings are important and suggest the potential of WTC dust-induced fibrotic sarcoid. It is likely that patient demographics and/or genetic factors influence the response to WTC dust injury and that these contribute to different pathological outcomes.
Keyphrases
- lymph node
- oxidative stress
- human health
- end stage renal disease
- transforming growth factor
- nitric oxide synthase
- health risk assessment
- neoadjuvant chemotherapy
- ejection fraction
- health risk
- newly diagnosed
- dna methylation
- chronic kidney disease
- diabetic rats
- high glucose
- peritoneal dialysis
- nitric oxide
- polycyclic aromatic hydrocarbons
- healthcare
- prognostic factors
- rheumatoid arthritis
- pulmonary fibrosis
- risk assessment
- squamous cell carcinoma
- signaling pathway
- systemic sclerosis
- ischemia reperfusion injury
- weight loss
- bariatric surgery
- patient reported outcomes
- endothelial cells
- pulmonary embolism
- rectal cancer